The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intranasal Drug Delivery System Market Research Report 2024
Synopsis
Due to the COVID-19 pandemic, the global Intranasal Drug Delivery System market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Intranasal Drug Delivery System market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Intranasal Drug Delivery System landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Nasal Drops accounting for % of the Intranasal Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Intranasal Drug Delivery System include Aptar Pharma, Nemera, Teleflex, Mystic Pharmaceuticals, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC and H&T Presspart Manufacturing Ltd., etc. In terms of revenue, the global 3 largest players have a % market share of Intranasal Drug Delivery System in 2021.
This report focuses on Intranasal Drug Delivery System volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Intranasal Drug Delivery System market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Intranasal Drug Delivery System Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Nasal Drops
Nasal Sprays
Nasal Gels
Nasal Suspensions and Emulsion
Nasal Powders
Segment by Application
Hospital
Clinic
Home Care
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Aptar Pharma
Nemera
Teleflex
Mystic Pharmaceuticals
Zeteo Medical
Johnson & Johnson
GlaxoSmithKline Plc
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd.
AstraZeneca Plc
Becton
BD
Novartis AG
Vectura Group Plc
Due to the COVID-19 pandemic, the global Intranasal Drug Delivery System market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Intranasal Drug Delivery System market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Intranasal Drug Delivery System landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Nasal Drops accounting for % of the Intranasal Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Intranasal Drug Delivery System include Aptar Pharma, Nemera, Teleflex, Mystic Pharmaceuticals, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC and H&T Presspart Manufacturing Ltd., etc. In terms of revenue, the global 3 largest players have a % market share of Intranasal Drug Delivery System in 2021.
This report focuses on Intranasal Drug Delivery System volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Intranasal Drug Delivery System market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Intranasal Drug Delivery System Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Nasal Drops
Nasal Sprays
Nasal Gels
Nasal Suspensions and Emulsion
Nasal Powders
Segment by Application
Hospital
Clinic
Home Care
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Aptar Pharma
Nemera
Teleflex
Mystic Pharmaceuticals
Zeteo Medical
Johnson & Johnson
GlaxoSmithKline Plc
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd.
AstraZeneca Plc
Becton
BD
Novartis AG
Vectura Group Plc
Index1 Intranasal Drug Delivery System Market Overview
1.1 Product Overview and Scope of Intranasal Drug Delivery System
1.2 Intranasal Drug Delivery System Segment by Type
1.2.1 Global Intranasal Drug Delivery System Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Nasal Drops
1.2.3 Nasal Sprays
1.2.4 Nasal Gels
1.2.5 Nasal Suspensions and Emulsion
1.2.6 Nasal Powders
1.3 Intranasal Drug Delivery System Segment by Application
1.3.1 Global Intranasal Drug Delivery System Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Intranasal Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Intranasal Drug Delivery System Revenue 2017-2028
1.4.2 Global Intranasal Drug Delivery System Sales 2017-2028
1.4.3 Intranasal Drug Delivery System Market Size by Region: 2017 Versus 2021 Versus 2028
2 Intranasal Drug Delivery System Market Competition by Manufacturers
2.1 Global Intranasal Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
2.2 Global Intranasal Drug Delivery System Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Intranasal Drug Delivery System Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Intranasal Drug Delivery System Manufacturing Sites, Area Served, Product Type
2.5 Intranasal Drug Delivery System Market Competitive Situation and Trends
2.5.1 Intranasal Drug Delivery System Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intranasal Drug Delivery System Players Market Share by Revenue
2.5.3 Global Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intranasal Drug Delivery System Retrospective Market Scenario by Region
3.1 Global Intranasal Drug Delivery System Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Intranasal Drug Delivery System Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Intranasal Drug Delivery System Market Facts & Figures by Country
3.3.1 North America Intranasal Drug Delivery System Sales by Country
3.3.2 North America Intranasal Drug Delivery System Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Intranasal Drug Delivery System Market Facts & Figures by Country
3.4.1 Europe Intranasal Drug Delivery System Sales by Country
3.4.2 Europe Intranasal Drug Delivery System Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intranasal Drug Delivery System Market Facts & Figures by Region
3.5.1 Asia Pacific Intranasal Drug Delivery System Sales by Region
3.5.2 Asia Pacific Intranasal Drug Delivery System Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Intranasal Drug Delivery System Market Facts & Figures by Country
3.6.1 Latin America Intranasal Drug Delivery System Sales by Country
3.6.2 Latin America Intranasal Drug Delivery System Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Intranasal Drug Delivery System Market Facts & Figures by Country
3.7.1 Middle East and Africa Intranasal Drug Delivery System Sales by Country
3.7.2 Middle East and Africa Intranasal Drug Delivery System Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Intranasal Drug Delivery System Historic Market Analysis by Type
4.1 Global Intranasal Drug Delivery System Sales Market Share by Type (2017-2022)
4.2 Global Intranasal Drug Delivery System Revenue Market Share by Type (2017-2022)
4.3 Global Intranasal Drug Delivery System Price by Type (2017-2022)
5 Global Intranasal Drug Delivery System Historic Market Analysis by Application
5.1 Global Intranasal Drug Delivery System Sales Market Share by Application (2017-2022)
5.2 Global Intranasal Drug Delivery System Revenue Market Share by Application (2017-2022)
5.3 Global Intranasal Drug Delivery System Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Aptar Pharma
6.1.1 Aptar Pharma Corporation Information
6.1.2 Aptar Pharma Description and Business Overview
6.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Aptar Pharma Intranasal Drug Delivery System Product Portfolio
6.1.5 Aptar Pharma Recent Developments/Updates
6.2 Nemera
6.2.1 Nemera Corporation Information
6.2.2 Nemera Description and Business Overview
6.2.3 Nemera Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Nemera Intranasal Drug Delivery System Product Portfolio
6.2.5 Nemera Recent Developments/Updates
6.3 Teleflex
6.3.1 Teleflex Corporation Information
6.3.2 Teleflex Description and Business Overview
6.3.3 Teleflex Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Teleflex Intranasal Drug Delivery System Product Portfolio
6.3.5 Teleflex Recent Developments/Updates
6.4 Mystic Pharmaceuticals
6.4.1 Mystic Pharmaceuticals Corporation Information
6.4.2 Mystic Pharmaceuticals Description and Business Overview
6.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Mystic Pharmaceuticals Intranasal Drug Delivery System Product Portfolio
6.4.5 Mystic Pharmaceuticals Recent Developments/Updates
6.5 Zeteo Medical
6.5.1 Zeteo Medical Corporation Information
6.5.2 Zeteo Medical Description and Business Overview
6.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Zeteo Medical Intranasal Drug Delivery System Product Portfolio
6.5.5 Zeteo Medical Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Johnson & Johnson Intranasal Drug Delivery System Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 GlaxoSmithKline Plc
6.6.1 GlaxoSmithKline Plc Corporation Information
6.6.2 GlaxoSmithKline Plc Description and Business Overview
6.6.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Product Portfolio
6.7.5 GlaxoSmithKline Plc Recent Developments/Updates
6.8 Aegis Therapeutics LLC
6.8.1 Aegis Therapeutics LLC Corporation Information
6.8.2 Aegis Therapeutics LLC Description and Business Overview
6.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Product Portfolio
6.8.5 Aegis Therapeutics LLC Recent Developments/Updates
6.9 H&T Presspart Manufacturing Ltd.
6.9.1 H&T Presspart Manufacturing Ltd. Corporation Information
6.9.2 H&T Presspart Manufacturing Ltd. Description and Business Overview
6.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Portfolio
6.9.5 H&T Presspart Manufacturing Ltd. Recent Developments/Updates
6.10 AstraZeneca Plc
6.10.1 AstraZeneca Plc Corporation Information
6.10.2 AstraZeneca Plc Description and Business Overview
6.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.10.4 AstraZeneca Plc Intranasal Drug Delivery System Product Portfolio
6.10.5 AstraZeneca Plc Recent Developments/Updates
6.11 Becton
6.11.1 Becton Corporation Information
6.11.2 Becton Intranasal Drug Delivery System Description and Business Overview
6.11.3 Becton Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Becton Intranasal Drug Delivery System Product Portfolio
6.11.5 Becton Recent Developments/Updates
6.12 BD
6.12.1 BD Corporation Information
6.12.2 BD Intranasal Drug Delivery System Description and Business Overview
6.12.3 BD Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.12.4 BD Intranasal Drug Delivery System Product Portfolio
6.12.5 BD Recent Developments/Updates
6.13 Novartis AG
6.13.1 Novartis AG Corporation Information
6.13.2 Novartis AG Intranasal Drug Delivery System Description and Business Overview
6.13.3 Novartis AG Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Novartis AG Intranasal Drug Delivery System Product Portfolio
6.13.5 Novartis AG Recent Developments/Updates
6.14 Vectura Group Plc
6.14.1 Vectura Group Plc Corporation Information
6.14.2 Vectura Group Plc Intranasal Drug Delivery System Description and Business Overview
6.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Vectura Group Plc Intranasal Drug Delivery System Product Portfolio
6.14.5 Vectura Group Plc Recent Developments/Updates
7 Intranasal Drug Delivery System Manufacturing Cost Analysis
7.1 Intranasal Drug Delivery System Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intranasal Drug Delivery System
7.4 Intranasal Drug Delivery System Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intranasal Drug Delivery System Distributors List
8.3 Intranasal Drug Delivery System Customers
9 Intranasal Drug Delivery System Market Dynamics
9.1 Intranasal Drug Delivery System Industry Trends
9.2 Intranasal Drug Delivery System Market Drivers
9.3 Intranasal Drug Delivery System Market Challenges
9.4 Intranasal Drug Delivery System Market Restraints
10 Global Market Forecast
10.1 Intranasal Drug Delivery System Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intranasal Drug Delivery System by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Intranasal Drug Delivery System by Type (2023-2028)
10.2 Intranasal Drug Delivery System Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intranasal Drug Delivery System by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Intranasal Drug Delivery System by Application (2023-2028)
10.3 Intranasal Drug Delivery System Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intranasal Drug Delivery System by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Intranasal Drug Delivery System by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Intranasal Drug Delivery System Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Intranasal Drug Delivery System Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Intranasal Drug Delivery System Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Intranasal Drug Delivery System Market Competitive Situation by Manufacturers in 2021
Table 5. Global Intranasal Drug Delivery System Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Intranasal Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Intranasal Drug Delivery System Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Intranasal Drug Delivery System Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Intranasal Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Intranasal Drug Delivery System Manufacturing Sites and Area Served
Table 11. Manufacturers Intranasal Drug Delivery System Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intranasal Drug Delivery System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intranasal Drug Delivery System as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Intranasal Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 16. Global Intranasal Drug Delivery System Sales Market Share by Region (2017-2022)
Table 17. Global Intranasal Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Intranasal Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 19. North America Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 20. North America Intranasal Drug Delivery System Sales Market Share by Country (2017-2022)
Table 21. North America Intranasal Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Intranasal Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 23. Europe Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 24. Europe Intranasal Drug Delivery System Sales Market Share by Country (2017-2022)
Table 25. Europe Intranasal Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Intranasal Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Intranasal Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Intranasal Drug Delivery System Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Intranasal Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Intranasal Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 31. Latin America Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Intranasal Drug Delivery System Sales Market Share by Country (2017-2022)
Table 33. Latin America Intranasal Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Intranasal Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Intranasal Drug Delivery System Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Intranasal Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Intranasal Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 39. Global Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 40. Global Intranasal Drug Delivery System Sales Market Share by Type (2017-2022)
Table 41. Global Intranasal Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Intranasal Drug Delivery System Revenue Share by Type (2017-2022)
Table 43. Global Intranasal Drug Delivery System Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Intranasal Drug Delivery System Sales (K Units) by Application (2017-2022)
Table 45. Global Intranasal Drug Delivery System Sales Market Share by Application (2017-2022)
Table 46. Global Intranasal Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Intranasal Drug Delivery System Revenue Share by Application (2017-2022)
Table 48. Global Intranasal Drug Delivery System Price by Application (2017-2022) & (US$/Unit)
Table 49. Aptar Pharma Corporation Information
Table 50. Aptar Pharma Description and Business Overview
Table 51. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Aptar Pharma Intranasal Drug Delivery System Product
Table 53. Aptar Pharma Recent Developments/Updates
Table 54. Nemera Corporation Information
Table 55. Nemera Description and Business Overview
Table 56. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Nemera Intranasal Drug Delivery System Product
Table 58. Nemera Recent Developments/Updates
Table 59. Teleflex Corporation Information
Table 60. Teleflex Description and Business Overview
Table 61. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Teleflex Intranasal Drug Delivery System Product
Table 63. Teleflex Recent Developments/Updates
Table 64. Mystic Pharmaceuticals Corporation Information
Table 65. Mystic Pharmaceuticals Description and Business Overview
Table 66. Mystic Pharmaceuticals Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Mystic Pharmaceuticals Intranasal Drug Delivery System Product
Table 68. Mystic Pharmaceuticals Recent Developments/Updates
Table 69. Zeteo Medical Corporation Information
Table 70. Zeteo Medical Description and Business Overview
Table 71. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Zeteo Medical Intranasal Drug Delivery System Product
Table 73. Zeteo Medical Recent Developments/Updates
Table 74. Johnson & Johnson Corporation Information
Table 75. Johnson & Johnson Description and Business Overview
Table 76. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Johnson & Johnson Intranasal Drug Delivery System Product
Table 78. Johnson & Johnson Recent Developments/Updates
Table 79. GlaxoSmithKline Plc Corporation Information
Table 80. GlaxoSmithKline Plc Description and Business Overview
Table 81. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. GlaxoSmithKline Plc Intranasal Drug Delivery System Product
Table 83. GlaxoSmithKline Plc Recent Developments/Updates
Table 84. Aegis Therapeutics LLC Corporation Information
Table 85. Aegis Therapeutics LLC Description and Business Overview
Table 86. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Aegis Therapeutics LLC Intranasal Drug Delivery System Product
Table 88. Aegis Therapeutics LLC Recent Developments/Updates
Table 89. H&T Presspart Manufacturing Ltd. Corporation Information
Table 90. H&T Presspart Manufacturing Ltd. Description and Business Overview
Table 91. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product
Table 93. H&T Presspart Manufacturing Ltd. Recent Developments/Updates
Table 94. AstraZeneca Plc Corporation Information
Table 95. AstraZeneca Plc Description and Business Overview
Table 96. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. AstraZeneca Plc Intranasal Drug Delivery System Product
Table 98. AstraZeneca Plc Recent Developments/Updates
Table 99. Becton Corporation Information
Table 100. Becton Description and Business Overview
Table 101. Becton Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Becton Intranasal Drug Delivery System Product
Table 103. Becton Recent Developments/Updates
Table 104. BD Corporation Information
Table 105. BD Description and Business Overview
Table 106. BD Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. BD Intranasal Drug Delivery System Product
Table 108. BD Recent Developments/Updates
Table 109. Novartis AG Corporation Information
Table 110. Novartis AG Description and Business Overview
Table 111. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Novartis AG Intranasal Drug Delivery System Product
Table 113. Novartis AG Recent Developments/Updates
Table 114. Vectura Group Plc Corporation Information
Table 115. Vectura Group Plc Description and Business Overview
Table 116. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Vectura Group Plc Intranasal Drug Delivery System Product
Table 118. Vectura Group Plc Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Intranasal Drug Delivery System Distributors List
Table 122. Intranasal Drug Delivery System Customers List
Table 123. Intranasal Drug Delivery System Market Trends
Table 124. Intranasal Drug Delivery System Market Drivers
Table 125. Intranasal Drug Delivery System Market Challenges
Table 126. Intranasal Drug Delivery System Market Restraints
Table 127. Global Intranasal Drug Delivery System Sales Forecast by Type (2023-2028) & (K Units)
Table 128. Global Intranasal Drug Delivery System Sales Market Share Forecast by Type (2023-2028)
Table 129. Global Intranasal Drug Delivery System Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 130. Global Intranasal Drug Delivery System Revenue Market Share Forecast by Type (2023-2028)
Table 131. Global Intranasal Drug Delivery System Sales Forecast by Application (2023-2028) & (K Units)
Table 132. Global Intranasal Drug Delivery System Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Intranasal Drug Delivery System Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Intranasal Drug Delivery System Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Intranasal Drug Delivery System Sales Forecast by Region (2023-2028) & (K Units)
Table 136. Global Intranasal Drug Delivery System Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Intranasal Drug Delivery System Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Intranasal Drug Delivery System Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intranasal Drug Delivery System
Figure 2. Global Intranasal Drug Delivery System Market Share by Type in 2021 & 2028
Figure 3. Nasal Drops Product Picture
Figure 4. Nasal Sprays Product Picture
Figure 5. Nasal Gels Product Picture
Figure 6. Nasal Suspensions and Emulsion Product Picture
Figure 7. Nasal Powders Product Picture
Figure 8. Global Intranasal Drug Delivery System Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Home Care
Figure 12. Others
Figure 13. Global Intranasal Drug Delivery System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Intranasal Drug Delivery System Market Size (2017-2028) & (US$ Million)
Figure 15. Global Intranasal Drug Delivery System Sales (2017-2028) & (K Units)
Figure 16. Intranasal Drug Delivery System Sales Share by Manufacturers in 2021
Figure 17. Global Intranasal Drug Delivery System Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Intranasal Drug Delivery System Players: Market Share by Revenue in 2021
Figure 19. Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Intranasal Drug Delivery System Sales Market Share by Region (2017-2022)
Figure 21. Global Intranasal Drug Delivery System Sales Market Share by Region in 2021
Figure 22. Global Intranasal Drug Delivery System Revenue Market Share by Region (2017-2022)
Figure 23. Global Intranasal Drug Delivery System Revenue Market Share by Region in 2021
Figure 24. United States Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Canada Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Germany Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. France Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. U.K. Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Italy Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Russia Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Japan Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. South Korea Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. India Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Australia Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. China Taiwan Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Indonesia Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Thailand Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Malaysia Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Intranasal Drug Delivery System Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Intranasal Drug Delivery System by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Intranasal Drug Delivery System
Figure 48. Manufacturing Process Analysis of Intranasal Drug Delivery System
Figure 49. Intranasal Drug Delivery System Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
